Camrelizumab vs Placebo in Patients With Triple-Negative Breast Cancer-Reply
JAMA
.
2025 May 27;333(20):1835-1836.
doi: 10.1001/jama.2025.1294.
Authors
Lei Fan
1
,
Zhi-Ming Shao
1
Affiliation
1
Department of Breast Surgery, Shanghai Cancer Center, Shanghai, China.
PMID:
40266589
DOI:
10.1001/jama.2025.1294
No abstract available